Clinical Trials Browser

Phase NA × Lenalidomide × 1 year × Clear all

NCT07299331 2025-12-23

Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma

Phase NA Not yet recruiting

Lymphoma, B-Cell, Marginal Zone

NCT07184424 2025-09-19

Lenalidomide

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular